Mobile Health (m-Health) in Retrospect: The Known Unknowns.

For nearly two decades, mobile health or (m-Health) was hailed as the most innovative and enabling area for the digital transformation of healthcare globally. However, this profound vision became a fleeting view since the inception and domination of smart phones, and the reorientation of the concept towards the exclusivity of global smart phone application markets and services. The global consumerization of m-Health in numerous disciplines of healthcare, fitness and wellness areas is unprecedented. However, this divergence between 'mobile health capitalism' and the 'science of mobile health' led to the creation of the 'm-Health schism'. This schism was sustained by the continued domination of the former on the expense of the latter. This also led to increased global m-Health inequality and divide between the much-perceived health and patient benefits and the markets of m-Health. This divergence was more evident in low and middle income (LMIC) countries compared to the developed world. This powerful yet misguided evolution of the m-Health was driven essentially by complex factors. These are presented in this paper as the 'known unknowns' or 'the obvious but sanctioned facts' of m-Health. These issues had surreptitiously contributed to this reorientation and the widening schism of m-Health. The collateral damage of this process was the increased shift towards understanding 'digital health' as a conjecture term associated with mobile health. However, to date, no clear or scientific views are discussed or analyzed on the actual differences and correlation aspects between digital and mobile health. This particular 'known unknown' is presented in detail in order to provide a rapprochement framework of this correlation and valid presentations between the two areas. The framework correlates digital health with the other standard ICT for the healthcare domains of telemedicine, telehealth and e-health. These are also increasingly used in conjunction with digital health, without clear distinctions between these terms and digital health. These critical issues have become timelier and more important to discuss and present, particularly after the world has been caught off guard by the COVID-19 pandemic. The much hyped and the profiteering digital health solutions developed in response of this pandemic provided a modest impact, and the benefits were mostly inadequate in mitigating the massive health, human, and economic impact of this pandemic. This largely commercial reorientation of mobile health was unable not only to predict the severity of the pandemic, but also unable to provide adequate digital tools or effective pre-emptive digital epidemiological shielding and guarding mechanisms against this devastating pandemic. There are many lessons to be learnt from the COVID-19 pandemic from the mobile and digital health perspectives, and lessons must be learnt from the past and to address the critical aspects discussed in this paper for better understanding of mobile health and effective tackling of future global healthcare challenges.

Evaluation of the effectiveness of mobile diabetes management system with social networking and cognitive behavioural therapy (CBT) for T2D.

BACKGROUND: In the Saudi Arabia region there are no previous studies related to the use of social networks combined with the management of mobile diabetes. In this sense, the aim of this feasibility investigation is to evaluate the application and utility of the SANAD system (Saudi Arabia Networking for Aiding Diabetes) to support Saudi type 2 diabetes adult patients. METHODS: Twenty patients from a clinic in Saudi Arabia-Dammam were recruited to use the SANAD system. The study design was a randomized controlled trial (RCT) with two groups: an intervention group using SANAD system and a control group using conventional diabetes treatment. Glycated hemoglobin (HbA1c), diabetes knowledge test (DKT) and Self-efficacy Scale (SES) were documented. RESULTS: Nineteen patients completed the study. Mean baseline HbA1c (%) was 8.14 (SD 1.20) and decreased to 7.54 (SD 0.96) after the SANAD intervention process [mean (SEM) decrease 0.600 (0.102)]. A paired-samples t-test showed this change to be significant (P=0.000). Linear regression analyzed each study group separately, and revealed that age significantly predicted change in HbA1c (%) in the intervention group, with older age (i.e., 41-50 years) associated with higher HbA1c (%) at 6 months, as compared with baseline values (ß=0.865, t=3.67, P<0.05). The mean diabetes knowledge score prior to the intervention (baseline) was 12.11 (SD 2.09), which rose to 14.56 (SD 1.59) afterward. This increase [mean (SEM), 2.44 (0.530)] was shown to be significant using the paired-samples t-test (P=0.002). Linear regression demonstrated that age, gender, and educational level were not related to increased diabetes knowledge in each study group. The mean self-efficacy score prior to the intervention (baseline) was 5.17 (SD 0.45), which rose to 6.17 (SD 0.39) afterward. This increase [mean (SEM), 0.944 (0.192)] was shown to be significant using the paired-samples t-test (P=0.001). Linear regression demonstrated that age, gender, and educational level were not related to increased self-efficacy in each study group. CONCLUSIONS: This study demonstrates that using of SANAD system is acceptable, and feasible in supporting diabetes care in Saudi Arabia. This study is the first in Saudi Arabia to demonstrate similar benefits of using this technology on social diabetes and management. A national clinical trial is needed to assess precise benefits of self-care and knowledge.

m-Health 2.0: New perspectives on mobile health, machine learning and big data analytics.

Mobile health (m-Health) has been repeatedly called the biggest technological breakthrough of our modern times. Similarly, the concept of big data in the context of healthcare is considered one of the transformative drivers for intelligent healthcare delivery systems. In recent years, big data has become increasingly synonymous with mobile health, however key challenges of 'Big Data and mobile health', remain largely untackled. This is becoming particularly important with the continued deluge of the structured and unstructured data sets generated on daily basis from the proliferation of mobile health applications within different healthcare systems and products globally. The aim of this paper is of twofold. First we present the relevant big data issues from the mobile health (m-Health) perspective. In particular we discuss these issues from the technological areas and building blocks (communications, sensors and computing) of mobile health and the newly defined (m-Health 2.0) concept. The second objective is to present the relevant rapprochement issues of big m-Health data analytics with m-Health. Further, we also present the current and future roles of machine and deep learning within the current smart phone centric m-health model. The critical balance between these two important areas will depend on how different stakeholder from patients, clinicians, healthcare providers, medical and m-health market businesses and regulators will perceive these developments. These new perspectives are essential for better understanding the fine balance between the new insights of how intelligent and connected the future mobile health systems will look like and the inherent risks and clinical complexities associated with the big data sets and analytical tools used in these systems. These topics will be subject for extensive work and investigations in the foreseeable future for the areas of data analytics, computational and artificial intelligence methods applied for mobile health.

Feasibility and acceptability of text messaging to support antenatal healthcare in Iraqi pregnant women: a pilot study.

OBJECTIVE: To determine the feasibility and acceptability of mobile health technology and its potential to improve antenatal care (ANC) services in Iraq. METHODS: This was a controlled experimental study conducted at primary health care centers. One hundred pregnant women who attended those centres for ANC were exposed to weekly text messages varying in content, depending on the week of gestation, while 150 women were recruited for the unexposed group. The number of ANC visits in the intervention and control groups, was the main outcome measure. The Mann-Whitney test and the Poisson regression model were the two main statistical tests used. RESULTS: More than 85% of recipients were in agreement with the following statements: "the client recommends this program for other pregnant women", "personal rating for the message as a whole" and "obtained benefit from the messages". There was a statistically significant increase in the median number of antenatal clinic visits from two to four per pregnancy, in addition to being relatively of low cost, and could be provided for a larger population with not much difference in the efforts. CONCLUSIONS: Text messaging is feasible, low cost and reasonably acceptable to Iraqi pregnant women, and encourages their ANC visits.

Design and Usability Evaluation of Social Mobile Diabetes Management System in the Gulf Region.

BACKGROUND: The prevalence of diabetes in the Gulf States is one of the highest globally. It is estimated that 20% of the population in the region has been diagnosed with diabetes and according to the International Diabetes Federation (IDF), five of the IDF's "top 10" countries for diabetes prevalence in 2011 and projected for 2030 are in this region. In recent years, there have been an increasing number of clinical studies advocating the use of mobile phone technology for diabetes self-management with improved clinical outcomes. However, there are few studies to date addressing the application of mobile diabetes management in the Gulf region, particularly in the Kingdom of Saudi Arabia (KSA), where there is exponential increase in mobile phone usage and access to social networking. OBJECTIVE: The objective of this paper is to present the design and development of a new mobile health system for social behavioral change and management tailored for Saudi patients with diabetes called Saudi Arabia Networking for Aiding Diabetes (SANAD). A usability study for the SANAD system is presented to validate the acceptability of using mobile technologies among patients with diabetes in the KSA and the Gulf region. METHODS: The SANAD system was developed using mobile phone technology with diabetes management and social networking modules. For the usability study the Questionnaire for User Interaction Satisfaction was used to evaluate the usability aspect of the SANAD system. A total of 33 users with type 2 diabetes participated in the study. RESULTS: The key modules of the SANAD system consist of (1) a mobile diabetes management module; (2) a social networking module; and (3) a cognitive behavioral therapy module for behavioral change issues. The preliminary results of the usability study indicated general acceptance of the patients in using the system with higher usability rating in patients with type 2 diabetes. CONCLUSIONS: We found that the acceptability of the system was high among Saudi patients with diabetes, and ongoing work in this research area is underway to conduct a clinical pilot study in the KSA for patients with type 2 diabetes. The wide deployment of such a system is timely and required in the Gulf region due to the wide use of mobile phones and social networking mediums.

A mobile diabetes management and educational system for type-2 diabetics in Saudi Arabia (SAED).

BACKGROUND: Diabetes is a chronic disease, with high prevalence across many nations, which is characterized by elevated level of blood glucose and risk of acute and chronic complication. The Kingdom of Saudi Arabia (KSA) has one of the highest levels of diabetes prevalence globally. It is well-known that the treatment of diabetes is complex process and requires both lifestyle change and clear pharmacologic treatment plan. To avoid the complication from diabetes, the effective behavioural change and extensive education and self-management is one of the key approaches to alleviate such complications. However, this process is lengthy and expensive. The recent studies on the user of smart phone technologies for diabetes self-management have proven to be an effective tool in controlling hemoglobin (HbA1c) levels especially in type-2 diabetic (T2D) patients. However, to date no reported study addressed the effectiveness of this approach in the in Saudi patients. This study investigates the impact of using mobile health technologies for the self-management of diabetes in Saudi Arabia. METHODS: In this study, an intelligent mobile diabetes management system (SAED), tailored for T2D patients in KSA was developed. A pilot study of the SAED system was conducted in Saudi Arabia with 20 diabetic patients for 6 months duration. The patients were randomly categorized into a control group who did not use the SAED system and an intervention group whom used the SAED system for their diabetes management during this period. At the end of the follow-up period, the HbA1c levels in the patients in both groups were measure together with a diabetes knowledge test was also conducted to test the diabetes awareness of the patients. RESULTS: The results of SAED pilot study showed that the patients in the intervention group were able to significantly decrease their HbA1c levels compared to the control group. The SAED system also enhanced the diabetes awareness amongst the patients in the intervention group during the trial period. These outcomes confirm the global studies on the effectiveness of smart phone technologies in diabetes management. The significance of the study is that this was one of the first such studies conducted on Saudi patients and of their acceptance for such technology in their diabetes self-management treatment plans. CONCLUSIONS: The pilot study of the SAED system showed that a mobile health technology can significantly improve the HbA1C levels among Saudi diabetic and improve their disease management plans. The SAED system can also be an effective and low-cost solution in improving the quality of life of diabetic patients in the Kingdom considering the high level of prevalence and the increasing economic burden of this disease.

A feasibility study of mobile phone text messaging to support education and management of type 2 diabetes in Iraq.

BACKGROUND: We undertook a feasibility study to evaluate feasibility and utility of short message services (SMSs) to support Iraqi adults with newly diagnosed type 2 diabetes. SUBJECTS AND METHODS: Fifty patients from a teaching hospital clinic in Basrah in the first year after diagnosis were recruited to receive weekly SMSs relating to diabetes self-management over 29 weeks. Numbers of messages received, acceptability, cost, effect on glycated hemoglobin (HbA1c), and diabetes knowledge were documented. RESULTS: Forty-two patients completed the study, receiving an average 22 of 28 messages. Mean knowledge score rose from 8.6 (SD 1.5) at baseline to 9.9 (SD 1.4) 6 months after receipt of SMSs (P=0.002). Baseline and 6-month knowledge scores correlated (r=0.297, P=0.049). Mean baseline HbA1c was 79 mmol/mol (SD 14 mmol/mol) (9.3% [SD 1.3%]) and decreased to 70 mmol/mol (SD 13 mmol/mol) (8.6% [SD 1.2%]) (P=0.001) 6 months after the SMS intervention. Baseline and 6-month values were correlated (r=0.898, P=0.001). Age, gender, and educational level showed no association with changes in HbA1c or knowledge score. Changes in knowledge score were correlated with postintervention HbA1c (r=-0.341, P=0.027). All patients were satisfied with text messages and wished the service to be continued after the study. The cost of SMSs was €0.065 per message. CONCLUSIONS: This study demonstrates SMSs are acceptable, cost-effective, and feasible in supporting diabetes care in the challenging, resource-poor environment of modern-day Iraq. This study is the first in Iraq to demonstrate similar benefits of this technology on diabetes education and management to those seen from its use in better-resourced parts of the world. A randomized controlled trial is needed to assess precise benefits on self-care and knowledge.

The potential of m-health systems for diabetes management in post conflict regions a case study from Iraq.

The recent developments of m-health technologies particularly in the developing world are increasing sharply due to the importance and accelerated adoption of these technologies in the developing countries. However, there are few if any studies on the effectiveness of mobile health in post conflict regions especially in the Middle East region. In this paper we describe the design, implementation and clinical outcomes of a feasibility study on mobile diabetes management in Basra, Southern Iraq as an exemplar for the effectiveness of mobile health technologies for improved healthcare delivery in similar post conflict regions. The key clinical outcome of this study indicated the lowering of HbA1C levels in the mobile health group indicating the potential of deploying such technologies in these regions where health resources are limited and challenging.

Monitoring heart disease and diabetes with mobile internet communications.

A telemedicine system is described for monitoring vital signs and general health indicators of patients with cardiac and diabetic conditions. Telemetry from wireless sensors and readings from other instruments are combined into a comprehensive set of measured patient parameters. Using a combination of mobile device applications and web browser, the data can be stored, accessed, and displayed using mobile internet communications to the central server. As an extra layer of security in the data transmission, information embedded in the data is used in its verification. The paper highlights features that could be enhanced from previous systems by using alternative components or methods.

Cross layer design for optimised region of interest of ultrasound video data over mobile WiMAX.

The application of advanced error concealment techniques applied as a post-process to conceal lost video information in error-prone channels, such as the wireless channel, demand additional processing at the receiver. This increases the delivery delay and needs more computational power. However, in general, only a small region within medical video is of interest to the physician and thus if only this area is considered, the number of computations can be curtailed. In this paper we present a technique whereby the Region of Interest (ROI) specified by the physician is used to delimit the area where the more complex concealment techniques are applied. A cross layer design approach in mobile WiMAX wireless communication environment is adopted in this paper to provide an optimized Quality of Experience (QoE) in the region that matters most to the mobile physician while relaxing the requirements in the background, ensuring real-time delivery. Results show that a diagnostically acceptable Peak Signal-to-Noise-Ratio (PSNR) of about 36 dB can still be achieved within reasonable decoding time.

Cross-layer ultrasound video streaming over mobile WiMAX and HSUPA networks.

It is well known that the evolution of 4G-based mobile multimedia network systems will contribute significantly to future mobile healthcare (m-health) applications that require high bandwidth and fast data rates. Central to the success of such emerging applications is the compatibility of broadband networks, such as mobile Worldwide Interoperability For Microwave Access (WiMAX) and High-Speed Uplink Packet Access (HSUPA), and especially their rate adaption issues combined with the acceptable real-time medical quality of service requirements. In this paper, we address the relevant challenges of cross-layer design requirements for real-time rate adaptation of ultrasound video streaming in mobile WiMAX and HSUPA networks. A comparative performance analysis of such approach is validated in two experimental m-health test bed systems for both mobile WiMAX and HSUPA networks. The experimental results have shown an improved performance of mobile WiMAX compared to the HSUPA using the same cross-layer optimization approach.

Development of m-health monitoring systems in India and Iraq.

Two separate projects have been carried out to implement m-health programs in India and Iraq, and, for each, this paper describes the work performed by the teams involved, presents results and details a number of lessons learned. In general, it is found that although India and Iraq have very different medical priorities, they pose similar issues when introducing m-health strategies.

Comparative analysis of genomic signal processing for microarray data clustering.

Genomic signal processing is a new area of research that combines advanced digital signal processing methodologies for enhanced genetic data analysis. It has many promising applications in bioinformatics and next generation of healthcare systems, in particular, in the field of microarray data clustering. In this paper we present a comparative performance analysis of enhanced digital spectral analysis methods for robust clustering of gene expression across multiple microarray data samples. Three digital signal processing methods: linear predictive coding, wavelet decomposition, and fractal dimension are studied to provide a comparative evaluation of the clustering performance of these methods on several microarray datasets. The results of this study show that the fractal approach provides the best clustering accuracy compared to other digital signal processing and well known statistical methods.

Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study.

BACKGROUND: Hypertension is a major risk factor for the long-term complications of diabetes. Mobile, self-measurement of blood pressure is emerging as a method to manage blood pressure in general, but its impact in patients with diabetes is unclear. METHODS: We randomized 137 patients with diabetes and hypertension to either mobile telemonitoring (n = 72) or usual care (n = 65). Clinic blood pressure was recorded at baseline and after 6 months. Patients in the intervention arm transmitted weekly blood pressure readings wirelessly, using adapted sensors via mobile phones to a central server. Clinicians received the data in real-time and using a web-based application provided management advice to the patient and their physicians. RESULTS: Systolic blood pressure fell significantly in the patients in the intervention group (mean [95% confidence interval], -6.5 [-0.8 to -12.2] mm Hg; P = 0.027) and remained unchanged in the control group (2.1 [9.3 to -5.0] mm Hg; P = 0.57). Patients within the intervention arm of African origin seemed to benefit more from the intervention. In addition, those who achieved a systolic blood pressure of <120 mm Hg had lower average blood sugars than those with higher readings (7.8 [SD 1.6] vs. 8.9 [SD 2.2] mmol/L; P = 0.02). CONCLUSIONS: In patients with diabetes, mobile telemonitoring has potential for delivering intensified care to improve blood pressure control, and its use may be associated with reduced exposure to hyperglycemia.

Provisioning of medical quality of services for HSDPA and mobile WiMAX in healthcare applications.

Mobile healthcare, or m-health, is an evolutionary concept that provides both mobility and an 'always connected' healthcare functionality. The development of this concept depends on how best the available bandwidth in (HSDPA/HSUPA) and emerging (Mobile WiMAX) networks can be correlated with the relevant medical quality of services issues. In this paper we address and discuss some of these issues and challenges. We also provide an example of a bandwidth demanding application to verify such provision mechanisms.

UK and Canadian perspectives of the effectiveness of mobile diabetes management systems.

The use of mobile technologies for self-monitoring of blood glucose and blood pressure for diabetes patients is becoming increasingly popular worldwide. This is propelled by the proliferation of the wider usage of mobile phones and other wireless technologies and computing platforms in the healthcare sector. Such technologies can play a pivotal role in chronic disease management and patient self-care. There have been several clinical trials in recent years on mobile diabetes management in UK and Canada. However, no studies to date have addressed and correlated the technological and clinical outcomes concerning the use of mobile chronic disease management systems for diabetes from the UK and Canadian perspectives. In this paper we address some of these correlative issues based on similar clinical trials on mobile type-2 diabetes management systems deployed in these two countries. In particular, the outcomes of these trials supported the use of telemonitoring for effective blood pressure control, but telemonitoring was less effective at managing blood glucose control. Some of the clinical results and challenges are presented together with future work and suggestions that aim to validate a generic platform for mobile diabetes management.

Technical and compliance considerations for mobile health self-monitoring of glucose and blood pressure for patients with diabetes.

Self-monitoring of blood glucose is an integral part of diabetes care which may be extended to other biometrics. Cellular and short range communication technologies will be important for the routine usage of these systems. However, the issues of follow-up and patient compliance with these emerging systems have not been yet studied evaluated but could be critical to the adoption of these technologies. We evaluated the impact of mobile telemonitoring on the intensification of care on blood pressure control and exposure to hyperglycaemia in patients with diabetes. We randomised 137 patients with diabetes to either mobile telemonitoring (n = 72) or usual care patients (n = 65) for 9 months. In this paper we present some of the clinical results with focus on blood pressure control hypertension and highlight some of the technical and compliance issues that were encountered.